Questions? +1 (202) 335-3939

Trusted News Since 1995

A service for global professionals · Sunday, May 4, 2025 · 809,349,652 Articles · 3+ Million Readers

News Search | All News Topics > ISO News Topics: By Country | By State

Search Tips

Here you can find useful examples and description about searching the news archive. Read it carefully to get the best results. If you need more help, please contact us.

Quick Overview

Searching is case insensitive. Words music and mUSIC return the same results.
Some of the common words like the, is, etc. are not included in your search.

Search Term Syntax

The symbol "|" stands for OR and symbol "&" stands for AND.

Term	Description
\|	Using \| operator gives you articles for every keyword in the search term.
&	Using & operator gives you only those articles that contain all keywords in the string.
" " (quotation marks)	Using quotation marks limits your search for exact phrases.
* (asterisk sign)	Using an asterisk sign gives you variations of aroot keyword. You cannot use it in phrases.
(parenthesis)	You can use parenthesis to adjust the priority of your search phrase evaluation (as common math/boolean expressions).

Examples

Keywords (search phrase)	Description
music	will search for any articles that contain the word music
music \| band \| song	will search for articles containing any of the keywords
nhl & hockey	will search for articles containing both words. (Note: & can be omitted in this case)
"white house" \| senate	will search for articles containing the phrase white house or the word senate
"flower show" & tulip	will search for articles containing both the phrase flower show and the word tulip
bank*	will search for articles containing bank, banks, banking, banker etc. Using * (asterisk sign) gives you variations of the root keyword.
student* & ( protest* \| demonstrat* )	will search for articles containing the words student or students, etc. in combinations with protest, protests, demonstrate, demonstration, etc.

Need more help? Contact us at our helpdesk.

Published on May 3, 2025

After AstraZeneca tells investors to stay away, Aston Martin and BAE Systems move annual general meetings online

By PATRICK TOOHER Updated: 16:50 EDT, 3 May 2025 Defence giant BAE Systems and luxury car maker Aston Martin have become the latest companies to make their annual general meetings online only. It follows The Mail on Sunday's revelation that Britain…

Source: This Is Money - Neutral
Published on May 3, 2025

AstraZeneca's fixed─dose triple─combination therapy, Breztri meets primary endpoints in KALOS & LOGOS phase III trials ...

Positive high-level results from the phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320 …

Source: Pharmabiz.com - Neutral
Published on May 2, 2025

AstraZeneca’s Breztri Therapy Meets Primary Goals In Late-Stage Trials To Treat Asthma: Retail’s Positive

AstraZeneca said on Friday that the full results from the two trials will be shared with regulatory authorities and presented at an upcoming medical meeting. AstraZeneca (AZN) said on Friday that it received positive results from two late-stage trials for …

Source: Asianet Newsable - Pending
Published on May 2, 2025

AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of annual sales of $3 billion to $5 billion for the 3-in-1 inhaler. Two phase 3 trials evaluating the effectiveness and safety of …

Source: Fierce Pharma - Neutral
Published on May 2, 2025

Cytokinetics reveals unexpected delay; AstraZeneca combo therapy hits in asthma

Today, a brief rundown of news involving Cytokinetics and AstraZeneca, as well as updates from Repare Therapeutics, Amicus Therapeutics and Pliant Therapeutics that you may have missed. The Food and Drug Administration has delayed an approval decision on …

Source: BioPharma Dive - Pending
Published on May 2, 2025

Pathos AI gets AstraZeneca funding as biotech plans to raise up to $400M

Source: Endpoints News - Neutral
Published on May 2, 2025

AstraZeneca's Triple-Combination Therapy Breztri Hits Primary Goals In Two Pivotal Studies For Asthma

On Friday, AstraZeneca Plc AZN reported topline data from Phase 3 KALOS and LOGOS trials in patients with uncontrolled asthma. KALOS and LOGOS trials assessed the efficacy and safety of Breztri Aerosphere (budesonide/glycopyrronium/formoterol …

Source: Benzinga - Neutral
Published on May 2, 2025

AstraZeneca's Triple Inhaled Therapy Meets Primary Endpoints in Phase 3 Trials of Uncontrolled Asthma

In adults and adolescents with uncontrolled asthma, inhaled triple combination therapy budesonide/glycopyrronium/formoterol (BGF) demonstrated statistically significant and clinically meaningful improvement in lung function compared to standard …

Source: Patient Care - Pending
Published on May 2, 2025

Alembic receives FDA nod for AstraZeneca clotbuster generic

New Delhi: Alembic Pharmaceuticals, Abbreviated New Drug Application (ANDA) for a cardiology blockbuster generic version has received approval from the US Food & Drug Administration (FDA). The approved drug Ticagrelor is a therapeutically equivalent to …

Source: ETPharma.com - Pending
Published on May 2, 2025

AstraZeneca’s triple-combo triumphs in two Phase III asthma trials

AstraZeneca’s triple-combination therapy Breztri Aerosphere (budesonide/glycopyrronium/formoterol fumarate) has met the primary endpoints in two Phase III asthma trials. Breztri met primary endpoints, demonstrating a statistically significant and …

Source: Clinical Trials Arena - Pending